Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1 Pt 1
pubmed:dateCreated
1998-8-25
pubmed:abstractText
Growth hormone (GH) reduces the catabolic side effects of steroid treatment due to its effects on tissue protein synthesis/degradation. Little attention is focused on hepatic amino acid degradation and urea synthesis. Five groups of rats were given 1) placebo, 2) prednisolone, 3) placebo, pair fed to the steroid group, 4) GH, and 5) prednisolone and GH. After 7 days, the in vivo capacity of urea N synthesis (CUNS) was determined by saturating alanine infusion, in parallel with measurements of liver mRNA levels of urea cycle enzymes, N contents of organs, N balance, and hormones. Prednisolone increased CUNS (micromol . min-1 . 100 g-1, mean +/- SE) from 9.1 +/- 1.0 (pair-fed controls) to 13.2 +/- 0.8 (P < 0.05), decreased basal blood alpha-amino N concentration from 4.2 +/- 0.5 to 3.1 +/- 0.3 mmol/l (P < 0.05), increased mRNA levels of the rate- and flux-limiting urea cycle enzymes by 20 and 65%, respectively (P < 0. 05), and decreased muscle N contents and N balance. In contrast, GH decreased CUNS from 6.1 +/- 0.9 (free-fed controls) to 4.2 +/- 0.5 (P < 0.05), decreased basal blood alpha-amino N concentration from 3. 8 +/- 0.3 to 3.2 +/- 0.2, decreased mRNA levels of the rate- and flux-limiting urea cycle enzymes to 60 and 40%, respectively (P < 0. 05), and increased organ N contents and N balance. Coadministration of GH abolished all steroid effects. We found that prednisolone increases the ability of amino N conversion into urea N and urea cycle gene expression. GH had the opposite effects and counteracted the N-wasting side effects of prednisolone.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0002-9513
pubmed:author
pubmed:issnType
Print
pubmed:volume
275
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
E79-86
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9688877-Animals, pubmed-meshheading:9688877-Arginase, pubmed-meshheading:9688877-Argininosuccinate Lyase, pubmed-meshheading:9688877-Argininosuccinate Synthase, pubmed-meshheading:9688877-Body Weight, pubmed-meshheading:9688877-Carbamoyl-Phosphate Synthase (Ammonia), pubmed-meshheading:9688877-DNA Probes, pubmed-meshheading:9688877-Energy Intake, pubmed-meshheading:9688877-Female, pubmed-meshheading:9688877-Gene Expression Regulation, Enzymologic, pubmed-meshheading:9688877-Growth Hormone, pubmed-meshheading:9688877-Liver, pubmed-meshheading:9688877-Organ Specificity, pubmed-meshheading:9688877-Ornithine Carbamoyltransferase, pubmed-meshheading:9688877-Prednisolone, pubmed-meshheading:9688877-RNA, Messenger, pubmed-meshheading:9688877-Rats, pubmed-meshheading:9688877-Rats, Wistar, pubmed-meshheading:9688877-Urea
pubmed:year
1998
pubmed:articleTitle
Effects of growth hormone on steroid-induced increase in ability of urea synthesis and urea enzyme mRNA levels.
pubmed:affiliation
Department of Medicine V, Aarhus University Hospital, DK-8000 Aarhus C, Denmark.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't